355 related articles for article (PubMed ID: 16084894)
1. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
[TBL] [Abstract][Full Text] [Related]
2. Effects of 17beta-estradiol, progesterone, synthetic progestins, tibolone, and raloxifene on vascular endothelial growth factor and Thrombospondin-1 messenger RNA in breast cancer cells.
Mirkin S; Wong BC; Archer DF
Int J Gynecol Cancer; 2006; 16 Suppl 2():560-3. PubMed ID: 17010073
[TBL] [Abstract][Full Text] [Related]
3. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
Mirkin S; Archer DF
Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
[TBL] [Abstract][Full Text] [Related]
4. Effect of tibolone and its metabolites on vascular endothelial growth factor isoforms 121 and 165 and thrombospondin-1 mRNA in Ishikawa cells.
Mirkin S; Mahony MC; Archer DF
Menopause; 2004; 11(1):82-8. PubMed ID: 14716187
[TBL] [Abstract][Full Text] [Related]
5. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
6. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Hyder SM; Murthy L; Stancel GM
Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of oestrone sulphatase activity by tibolone and its metabolites.
Purohit A; Malini B; Hooymans C; Newman SP
Horm Metab Res; 2002 Jan; 34(1):1-6. PubMed ID: 11832993
[TBL] [Abstract][Full Text] [Related]
8. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
Seeger H; Wallwiener D; Mueck AO
Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
[TBL] [Abstract][Full Text] [Related]
9. Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, and 17beta-estradiol on vascular endothelial growth factor isomers 121 and 165 in Ishikawa cells.
Archer DF; Navarro FJ; Leslie S; Mirkin S
Fertil Steril; 2004 Jan; 81(1):165-70. PubMed ID: 14711561
[TBL] [Abstract][Full Text] [Related]
10. Tibolone and its metabolites inhibit invasion of human mammary carcinoma cells in vitro.
Vanhoecke BW; Bracke ME; Kloosterboer HJ; Depypere HT
Maturitas; 2006 Jun; 54(3):229-37. PubMed ID: 16581209
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and proliferation in breast cancer cells, cultured in vitro: effects of SERMs.
Werner HM; Franke HR; Vermes I
Climacteric; 2005 Sep; 8(3):294-9. PubMed ID: 16390761
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
Mueck AO; Seeger H; Wallwiener D
Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
[TBL] [Abstract][Full Text] [Related]
13. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
[TBL] [Abstract][Full Text] [Related]
14. [Effect of estrogen and progesterone on the expression of VEGF mRNA in epithelial ovarian cancer cell line].
Li H; Sun H
Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):264-7. PubMed ID: 15312358
[TBL] [Abstract][Full Text] [Related]
15. The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells.
Krämer EA; Seeger H; Krämer B; Wallwiener D; Mueck AO
Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):77-83. PubMed ID: 16460873
[TBL] [Abstract][Full Text] [Related]
16. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
[TBL] [Abstract][Full Text] [Related]
17. Effect of estrogen, tamoxifen and epidermal growth factor on the transcriptional regulation of vascular endothelial growth factor in breast cancer cells.
Lee JE; Chung KW; Han W; Kim SW; Kim SW; Shin HJ; Bae JY; Noh DY
Anticancer Res; 2004; 24(6):3961-4. PubMed ID: 15736439
[TBL] [Abstract][Full Text] [Related]
18. Effects of mifepristone on vascular endothelial growth factor and thrombospondin-1 mRNA in Ishikawa cells: implication for the endometrial effects of mifepristone.
Mirkin S; Archer DF
Contraception; 2004 Oct; 70(4):327-33. PubMed ID: 15451338
[TBL] [Abstract][Full Text] [Related]
19. Curcumin inhibits MPA-induced secretion of VEGF from T47-D human breast cancer cells.
Carroll CE; Ellersieck MR; Hyder SM
Menopause; 2008; 15(3):570-4. PubMed ID: 18467956
[TBL] [Abstract][Full Text] [Related]
20. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
